Evaluation of the effect of tacrolimus-loaded liquid crystalline nanoparticles on psoriasis-like skin inflammation

Journal of Dermatological Treatment

Volumn 25, Issue 1, 2014, Pages 22-25

  Thapa, Raj Kumar ^a   Yoo, Bong Kyu ^b  

^a Yeungnam University   (South Korea)

^b Gachon University   (South Korea)

Author keywords

Liquid crystalline nanoparticles; Psoriasis like skin inflammation; Tacrolimus

Indexed keywords

GLYCEROL OLEATE; LIQUID CRYSTALLINE NANOPARTICLE; NANOPARTICLE; OLEIC ACID; PROPYLENE GLYCOL; TACROLIMUS; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG RETENTION; IN VITRO STUDY; IN VIVO STUDY; LIQUID CRYSTAL; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PSORIASIS; PSORIASIS AREA AND SEVERITY INDEX; SKIN PERMEABILITY;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; DERMATITIS; DRUG DELIVERY SYSTEMS; GLYCERIDES; INFLAMMATION; MICE; NANOPARTICLES; OLEIC ACID; PARTICLE SIZE; PSORIASIS; SKIN; SKIN ABSORPTION; TACROLIMUS;

EID: 84890535670     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546634.2012.755250     Document Type: Article

References (16)

1. Johnsson M, Barauskas J, Norlin A, Tiberg F. Physicochemical and drug delivery aspects of lipid-based liquid crystalline nanoparticles: a case study of intravenously administered propofol. J Nanosci Nanotechnol. 2006;9-10:3017-3024.
2. Esposito E, Cortesi R, Drechsler M, Paccamiccio L, Mariani P, Contado C, et al. Liquid crystalline nanoparticle dispersions as delivery systems for percutaneous administration of indomethacin. Pharm Res. 2005;22:2163-2173.
3. Zhao XY, Zhang J, Zheng LQ, Li DH. Studies of cubosomes as a sustained drug delivery system. J Disp Sci Tech. 2004;25:795-799.
4. Spicer PT. Progress in liquid crystalline dispersions: cubosomes. Curr Opin Colloid In. 2005;10:274-279.
5. Naik A, Pechtold LARM, Potts RO, Guy RH. Mechanism of oleic acid-induced skin penetration enhancement in vivo in humans. J Controll Rel. 1995;37:299-306.
6. Lai J, Chen J, Lu Y, Sun J, Hu F, Yin Z, et al. Glyceryl monooleate/ poloxamer407 cubicnanoparticles as oral drugdelivery systems: I.In vitro evaluation and enhanced oral bioavailability of the poorly water-soluble drug simvastatin. AAPS Pharm Sci Tech. 2009;10:960-966.
7. Spicer PT. Cubosomes: bicontinuous cubic liquid crystalline nanostructured particles. In Schwarz JA, Contescu C, Putyera K, eds. Marcel dekker encyclopedia of nanoscience and nanotechnology. New York: Marcel dekker; 2003. pp 881-892.
8. Yoo J, Shanmugam S, Song CK, Kim DD, Choi HG, Yong CS, et al. Skin penetration and retention of L-ascorbic acid 2-phosphate using multilamellar vesicles. Arch Pharm Res. 2008;31:1652-1658.
9. van der Fits L, Mourits S, Voerman JSA, Kant M, Boon L, Laman JD, et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol. 2009;182: 5836-5845.
10. Winter R. Synchrotron X-ray and neutron small-angle scattering of lyotropic lipid mesophases, model biomembranes and proteins in solution at high pressure. Biochim Biophys Acta. 2002;1595:160-184.
11. Tamura S, Ohike A, Ibuki R, Amidon GL, Yamashita S. Tacrolimus is a class II low-solubility high permeability drug: the effect of P-glycoprotein efflux on regional permeability of tacrolimus in rats. J Pharm Sci. 2002;91:719-729.
12. Trickler WJ, Nagvekar AA, Dash AK. A novel nanoparticle formulation for sustained paclitaxel delivery. AAPS PharmSciTech. 2008;9: 486-493.
13. Gilliet M, Conrad C, Geiges M, Cozzio A, ThürlimannW, Burg G, et al. Psoriasis triggered by Toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. Arch Dermatol. 2004;140:1490-1495.
14. Wu JK, Siller G, Strutton G. Psoriasis induced by topical imiquimod. Australas J Dermatol. 2004;45:47-50.
15. Rajan N, Langtry JA. Generalized exacerbation of psoriasis associated with imiquimod cream treatment of superficial basal cell carcinomas. Clin Exp Dermatol. 2006;31:140-141.
16. Fanti PA, Dika E, Vaccari S, Miscial C, Varotti C. Generalized psoriasis induced by topical treatment of actinic keratosis with imiquimod. Int J Dermatol. 2006;45:1464-1465.